These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 30742062)

  • 21. Mitochondrial abnormalities in inclusion-body myositis.
    Oldfors A; Moslemi AR; Jonasson L; Ohlsson M; Kollberg G; Lindberg C
    Neurology; 2006 Jan; 66(2 Suppl 1):S49-55. PubMed ID: 16432145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amyotrophic lateral sclerosis: dash-like accumulation of phosphorylated TDP-43 in somatodendritic and axonal compartments of somatomotor neurons of the lower brainstem and spinal cord.
    Braak H; Ludolph A; Thal DR; Del Tredici K
    Acta Neuropathol; 2010 Jul; 120(1):67-74. PubMed ID: 20379728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calcium dysregulation, functional calpainopathy, and endoplasmic reticulum stress in sporadic inclusion body myositis.
    Amici DR; Pinal-Fernandez I; Mázala DA; Lloyd TE; Corse AM; Christopher-Stine L; Mammen AL; Chin ER
    Acta Neuropathol Commun; 2017 Mar; 5(1):24. PubMed ID: 28330496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Widespread Mislocalization of FUS Is Associated With Mitochondrial Abnormalities in Skeletal Muscle in Amyotrophic Lateral Sclerosis With FUS Mutations.
    Yu M; Zhao X; Wu W; Wang Q; Liu J; Zhang W; Yuan Y; Hong D; Wang Z; Deng J
    J Neuropathol Exp Neurol; 2022 Feb; 81(3):172-181. PubMed ID: 35139534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteasomal expression, induction of immunoproteasome subunits, and local MHC class I presentation in myofibrillar myopathy and inclusion body myositis.
    Ferrer I; Martín B; Castaño JG; Lucas JJ; Moreno D; Olivé M
    J Neuropathol Exp Neurol; 2004 May; 63(5):484-98. PubMed ID: 15198127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia.
    Weihl CC; Temiz P; Miller SE; Watts G; Smith C; Forman M; Hanson PI; Kimonis V; Pestronk A
    J Neurol Neurosurg Psychiatry; 2008 Oct; 79(10):1186-9. PubMed ID: 18796596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Muscle-dominant wild-type TDP-43 expression induces myopathological changes featuring tubular aggregates and TDP-43-positive inclusions.
    Tawara N; Yamashita S; Kawakami K; Kurashige T; Zhang Z; Tasaki M; Yamamoto Y; Nishikami T; Doki T; Zhang X; Matsuo Y; Kimura E; Tawara A; Maeda Y; Hauschka SD; Maruyama H; Ando Y
    Exp Neurol; 2018 Nov; 309():169-180. PubMed ID: 30130494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Light and electron microscopic immunolocalization of presenilin 1 in abnormal muscle fibers of patients with sporadic inclusion-body myositis and autosomal-recessive inclusion-body myopathy.
    Askanas V; Engel WK; Yang CC; Alvarez RB; Lee VM; Wisniewski T
    Am J Pathol; 1998 Apr; 152(4):889-95. PubMed ID: 9546349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optineurin is potentially associated with TDP-43 and involved in the pathogenesis of inclusion body myositis.
    Yamashita S; Kimura E; Tawara N; Sakaguchi H; Nakama T; Maeda Y; Hirano T; Uchino M; Ando Y
    Neuropathol Appl Neurobiol; 2013 Jun; 39(4):406-16. PubMed ID: 22860700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired autophagy in sporadic inclusion-body myositis and in endoplasmic reticulum stress-provoked cultured human muscle fibers.
    Nogalska A; D'Agostino C; Terracciano C; Engel WK; Askanas V
    Am J Pathol; 2010 Sep; 177(3):1377-87. PubMed ID: 20616343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ubiquitin immunostaining and inclusion body myositis: study of 30 patients with inclusion body myositis.
    Prayson RA; Cohen ML
    Hum Pathol; 1997 Aug; 28(8):887-92. PubMed ID: 9269823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Motor-Coordinative and Cognitive Dysfunction Caused by Mutant TDP-43 Could Be Reversed by Inhibiting Its Mitochondrial Localization.
    Wang W; Arakawa H; Wang L; Okolo O; Siedlak SL; Jiang Y; Gao J; Xie F; Petersen RB; Wang X
    Mol Ther; 2017 Jan; 25(1):127-139. PubMed ID: 28129109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic stress induces formation of stress granules and pathological TDP-43 aggregates in human ALS fibroblasts and iPSC-motoneurons.
    Ratti A; Gumina V; Lenzi P; Bossolasco P; Fulceri F; Volpe C; Bardelli D; Pregnolato F; Maraschi A; Fornai F; Silani V; Colombrita C
    Neurobiol Dis; 2020 Nov; 145():105051. PubMed ID: 32827688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of the mitochondrial DNA abnormalities in the skeletal muscle of patients with inclusion body myositis.
    Horvath R; Fu K; Johns T; Genge A; Karpati G; Shoubridge EA
    J Neuropathol Exp Neurol; 1998 May; 57(5):396-403. PubMed ID: 9596410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel demonstration of conformationally modified tau in sporadic inclusion-body myositis muscle fibers.
    Nogalska A; D'Agostino C; Engel WK; Askanas V
    Neurosci Lett; 2011 Oct; 503(3):229-33. PubMed ID: 21896314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coexistence of TDP-43 and C5b-9 staining of muscle in a patient with inclusion body myositis.
    Law C; Li H; Bandyopadhyay S
    BMJ Case Rep; 2021 Feb; 14(2):. PubMed ID: 33563691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of p62/SQSTM1 in sporadic inclusion body myositis.
    Nakano S; Oki M; Kusaka H
    Neuromuscul Disord; 2017 Apr; 27(4):363-369. PubMed ID: 28159418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unravelling inclusion body myositis using a patient-derived fibroblast model.
    Cantó-Santos J; Valls-Roca L; Tobías E; García-García FJ; Guitart-Mampel M; Esteve-Codina A; Martín-Mur B; Casado M; Artuch R; Solsona-Vilarrasa E; Fernandez-Checa JC; García-Ruiz C; Rentero C; Enrich C; Moreno-Lozano PJ; Milisenda JC; Cardellach F; Grau-Junyent JM; Garrabou G
    J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):964-977. PubMed ID: 36860172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Difference in expression of phosphorylated tau epitopes between sporadic inclusion-body myositis and hereditary inclusion-body myopathies.
    Mirabella M; Alvarez RB; Bilak M; Engel WK; Askanas V
    J Neuropathol Exp Neurol; 1996 Jul; 55(7):774-86. PubMed ID: 8965093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The RNA-binding motif 45 (RBM45) protein accumulates in inclusion bodies in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) patients.
    Collins M; Riascos D; Kovalik T; An J; Krupa K; Krupa K; Hood BL; Conrads TP; Renton AE; Traynor BJ; Bowser R
    Acta Neuropathol; 2012 Nov; 124(5):717-32. PubMed ID: 22993125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.